Microglia and neuroprotection: From in vitro studies to therapeutic applications

Progress in Neurobiology

Volumn 92, Issue 3, 2010, Pages 293-315

  Polazzi, Elisabetta ^a   Monti, Barbara ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Gene therapy; In vitro models; Microglia; Neurodegenerative diseases; Neuroprotection

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA SYNUCLEIN; ANTIINFLAMMATORY AGENT; CANNABINOID RECEPTOR AGONIST; CYCLOOXYGENASE 2 INHIBITOR; FLURBIPROFEN; GLATIRAMER; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TAU PROTEIN; THALIDOMIDE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOIMMUNE DISEASE; BRADYCARDIA; CELL FUNCTION; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; IMMUNIZATION; IN VITRO STUDY; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNITY; BRAIN; GENE THERAPY; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; MICROGLIA; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 77956537707     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.06.009     Document Type: Review

References (470)

1. Aarum J., Sandberg K., Haeberlein S.L., Persson M.A. Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15983-'.
2. AD2000 Collaborative Group, Bentham, P., Gray, R., Sellwood, E., Hills, R., Crome, P., Raftery, J., 2008. Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. Lancet Neurol., 7, 41-49.
3. Adams R.A., Bauer J., Flick M.J., Sikorski S.L., Nuriel T., Lassmann H., Degen J.L., Akassoglou K. The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J. Exp. Med. 2007, 204:571-582.
4. ADAPT Research Group, Lyketsos, C.G., Breitner, J.C., Green, R.C., Martin, B.K., Meinert, C., Piantadosi, S., Sabbagh, M., 2007. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology, 68, 1800-1808.
5. Aebischer P., Schluep M., Déglon N., Joseph J.M., Hirt L., Heyd B., Goddard M., Hammang J.P., Zurn A.D., Kato A.C., Regli F., Baetge E.E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 1996, 2:696-699.
6. Aisen P.S. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol. 2002, 1:279-284.
7. Aisen P.S., Davis K.L., Berg J.D., Schafer K., Campbell K., Thomas R.G., Weiner M.F., Farlow M.R., Sano M., Grundman M., Thal L.J. A randomized controlled trial of prednisone in Alzheimer's disease. Neurology 2000, 54:588-893. Alzheimer's Disease Cooperative Study.
8. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., Farlow, M.R., Jin, S., Thomas, R.G., Thal, L.J., Alzheimer's Disease Cooperative Study, 2003. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA, 289, 2819-2826.
9. Aldskogius H. Microglia in neuroregeneration. Microsc. Res. Tech. 2001, 54:40-46.
10. Alexianu M.E., Kozovska M., Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001, 57:1282-1289.
11. Aloisi F. Immune function of microglia. Glia 2001, 36:165-179.
12. Andersen K., Launer L.J., Ott A., Hoes A.W., Breteler M.M., Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995, 45:1441-1445.
13. Andjelkovic A.V., Nikolic B., Pachter J.S., Zecevic N. Macrophages/microglial cells in human central nervous system during development: an immunohistochemical study. Brain Res. 1998, 814:13-25.
14. Angelov D.N., Waibel S., Guntinas-Lichius O., Lenzen M., Neiss W.F., Tomov T.L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., Schwartz M. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4790-4795.
15. Appel S.H. CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. J. Clin. Invest. 2009, 119:13-15.
16. Appel S.H., Beers D.R., Henkel J.S. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?. Trends Immunol. 2010, 31:7-17.
17. Appel S.H., Engelhardt J.I., Henkel J.S., Siklos L., Beers D.R., Yen A.A., Simpson E.P., Luo Y., Carrum G., Heslop H.E., Brenner M.K., Popat U. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008, 71:1326-1334.
18. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 1996, 43:190-202.
19. Arnhold S., Kreppel F., Kandirali S., Lenartz D., Klinz F.J., Sturm V., Kochanek S., Andressen C., Addicks K. Intracerebral transplantation and successful integration of astrocytes following genetic modification with a high-capacity adenoviral vector. Cell. Transplant. 2002, 11:663-670.
20. Asheuer M., Pflumio F., Benhamida S., Dubart-Kupperschmitt A., Fouquet F., Imai Y., Aubourg P., Cartier N. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3557-3562.
21. Ashwell K. Microglia and cell death in the developing mouse cerebellum. Dev. Brain Res. 1990, 55:219-230.
22. Avidan H., Kipnis J., Butovsky O., Caspi R.R., Schwartz M. Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells. Eur. J. Immunol. 2004, 34:3434-3445.
23. Azizi S.A., Stokes D., Augelli B.J., DiGirolamo C., Prockop D.J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3908-3913.
24. Backlund E.O., Granberg P.O., Hamberger B., Knutsson E., Mårtensson A., Sedvall G., Seiger A., Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J. Neurosurg. 1985, 62:169-173.
25. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., Schenk D., Hyman B.T. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 2001, 7:369-372.
26. Bahat-Stroomza M., Barhum Y., Levy Y.S., Karpov O., Bulvik S., Melamed E., Offen D. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J. Mol. Neurosci. 2009, 39:199-210.
27. Bahr B.A. Long-term hippocampal slices: a model system for investigating synaptic mechanisms and pathologic processes. J. Neurosci. Res. 1995, 42(3):294-305.
28. Bakalash S., Shlomo G.B., Aloni E., Shaked I., Wheeler L., Ofri R., Schwartz M. T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. J. Mol. Med. 2005, 83:904-916.
29. Banati R.B., Daniel S.E., Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 1998, 13:221-227.
30. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
31. Banati R.B., Graeber M.B. Surveillance, intervention and cytotoxicity: is there a protective role of microglia?. Dev. Neurosci. 1994, 16:114-127.
32. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 2000, 6:916-919.
33. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388:878-881.
34. Barkats M., Bilang-Bleuel A., Buc-Caron M.H., Castel-Barthe M.N., Corti O., Finiels F., Horellou P., Revah F., Sabate O., Mallet J. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. Prog. Neurobiol. 1998, 55:333-341.
35. Batchelor P.E., Liberatore G.T., Wong J.Y., Porritt M.J., Frerichs F., Donnan G.A., Howells D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 1999, 19:1708-1716.
36. Battista D., Ferrari C.C., Gage F.H., Pitossi F.J. Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus. Eur. J. Neurosci. 2006, 23:83-93.
37. Beauvillain C., Donno S., Jarry U., Scotet M., Gascan H., Delneste Y., Guermonprez P., Jeannin P., Couez D. Neonatal and adult microglia cross-present exogenous antigens. Glia 2008, 56:69-77.
38. Beck H., Voswinckel R., Wagner S., Ziegelhoeffer T., Heil M., Helisch A., Schaper W., Acker T., Hatzopoulos A.K., Plate K.H. Participation of bone marrow-derived cells in long-term repair processes after experimental stroke. J. Cereb. Blood Flow Metab. 2003, 23:709-717.
39. Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16021-16026.
40. Beers D.R., Henkel J.S., Zhao W., Wang J., Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15558-15563.
41. Benoit M., Desnues B., Mege J.L. Macrophage polarization in bacterial infections. J. Immunol. 2008, 181:3733-3739.
42. Berezovskaya O., Maysinger D., Fedoroff S. The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int. J. Dev. Neurosci. 1995, 13:285-299.
43. Bialecka M., Klodowska-Duda G., Kurzawski M., Slawek J., Opala G., Bialecki P., Safranow K., Droździk M. Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch. Med. Res. 2007, 38:858-863.
44. Biffi A., De Palma M., Quattrini A., Del Carro U., Amadio S., Visigalli I., Sessa M., Fasano S., Brambilla R., Marchesini S., Bordignon C., Naldini L. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J. Clin. Invest. 2004, 113:1118-1129.
45. Binstadt B.A., Patel P.-R., Alencar H., Nigrovic P.-A., Lee D.M., Mahmood U., Weissleder R., Mathis D., Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 2006, 7:284-292.
46. Bitting L., Naidu A., Cordell B., Murphy G.M. Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. J. Biol. Chem. 1996, 271:16084-16089.
47. Björklund T., Kirik D. Scientific rationale for the development of gene therapy strategies for Parkinson's disease. Biochim. Biophys. Acta 2009, 1792:703-713.
48. Björkqvist M., Wild E.J., Thiele J., Silvestroni A., Andre R., Lahiri N., Raibon E., Lee R.V., Benn C.L., Soulet D., Magnusson A., Woodman B., Landles C., Pouladi M.A., Hayden M.R., Khalili-Shirazi A., Lowdell M.W., Brundin P., Bates G.P., Leavitt B.R., Möller T., Tabrizi S.J. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J. Exp. Med. 2008, 205:1869-1877.
49. Blackburn D., Sargsyan S., Monk P.N., Shaw P.J. Astrocyte function and role in motor neuron disease: a future therapeutic target?. Glia 2009, 57:1251-1264.
50. Blair M., Pease M.E., Hammond J., Valenta D., Kielczewski J., Levkovitch-Verbin H., Quigley H. Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Invest. Ophthalmol. Vis. Sci. 2005, 46:884-890.
51. Blandini F., Cova L., Armentero M.T., Zennaro E., Levandis G., Bossolasco P., Calzarossa C., Mellone M., Giuseppe B., Deliliers G.L., Polli E., Nappi G., Silani V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 2010, 19:203-217.
52. Boillée S., Cleveland D.W. Revisiting oxidative damage in ALS: microglia. Nox, and mutant SOD1. J. Clin. Invest. 2008, 118:474-478.
53. Boillée S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
54. Bornemann K.D., Wiederhold K.H., Pauli C., Ermini F., Stalder M., Schnell L., Sommer B., Jucker M., Staufenbiel M. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 2001, 1:63-73.
55. Britschgi M., Wyss-Coray T. Immune cells may fend off Alzheimer disease. Nat. Med. 2007, 13:408-409.
56. Brody D.L., Holtzman D.M. Active and passive immunotherapy for neurodegenerative disorders. Annu. Rev. Neurosci. 2008, 31:175-193.
57. Brown H.C., Perry V.H. Differential adhesion of macrophages to white and grey matter in an in vitro assay. Glia 1998, 23:361-373.
58. Browne K.D., Iwata A., Putt M.E., Smith D.H. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp. Neurol. 2006, 201:301-307.
59. Butovsky O., Koronyo-Hamaoui M., Kunis G., Ophir E., Landa G., Cohen H., Schwartz M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11784-11789.
60. Butovsky O., Kunis G., Koronyo-Hamaoui M., Schwartz M. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur. J. Neurosci. 2007, 26:413-416.
61. Butovsky O., Talpalar A.E., Ben-Yaakov K., Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol. Cell. Neurosci. 2005, 29:381-393.
62. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A.E., Pluchino S., Martino G., Schwartz M. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 2006, 31:149-160.
63. Cagnin A., Rossor M., Sampson E.L., Mackinnon T., Banati R.B. In vivo detection of microglial activation in frontotemporal dementia. Ann. Neurol. 2004, 56:894-897.
64. Cao C., Arendash G.W., Dickson A., Mamcarz M.B., Lin X., Ethell D.W. Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS. Neurobiol. Dis. 2009, 34:63-70.
65. Carson M.J., Crane J., Xie A.X. Modeling CNS microglia: the quest to identify predictive models. Drug Discov. Today Dis. Models 2008, 5:19-25.
66. Cartier N., Hacein-Bey-Abina S., Bartholomae C.C., Veres G., Schmidt M., Kutschera I., Vidaud M., Abel U., Dal-Cortivo L., Caccavelli L., Mahlaoui N., Kiermer V., Mittelstaedt D., Bellesme C., Lahlou N., Lefrère F., Blanche S., Audit M., Payen E., Leboulch P., l'Homme B., Bougnères P., Von Kalle C., Fischer A., Cavazzana-Calvo M., Aubourg P. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326:818-823.
67. Castaño A., Herrera A.J., Cano J., Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem. 2002, 81:150-157.
68. Chan W.Y., Kohsaka S., Rezaie P. The origin and cell lineage of microglia: new concepts. Brain Res. Rev. 2007, 53:344-354.
69. Chen H., Jacobs E., Schwarzschild M.A., McCullough M.L., Calle E.E., Thun M.J., Ascherio A. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann. Neurol. 2005, 58:963-967.
70. Chiu I.M., Chen A., Zheng Y., Kosaras B., Tsiftsoglou S.A., Vartanian T.K., Brown R.H., Carroll M.C. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17913-17918.
71. Chiu I.M., Phatnani H., Kuligowski M., Tapia J.C., Carrasco M.A., Zhang M., Maniatis T., Carroll M.C. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20960-20965.
72. Chung H., Brazil M.I., Soe T.T., Maxfield F.R. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J. Biol. Chem. 1999, 274:32301-32308.
73. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillée S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown R.H., Julien J.P., Goldstein L.S., Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302:113-117.
74. Colin A., Faideau M., Dufour N., Auregan G., Hassig R., Andrieu T., Brouillet E., Hantraye P., Bonvento G., Déglon N. Engineered lentiviral vector targeting astrocytes in vivo. Glia 2009, 667-679.
75. Combs C.K., Karlo J.C., Kao S.C., Landreth G.E. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 2001, 21:1179-1188.
76. Corti S., Locatelli F., Donadoni C., Guglieri M., Papadimitriou D., Strazzer S., Del Bo R., Comi G.P. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004, 27:2518-2532.
77. Cras P., Kawai M., Siedlak S., Perry G. Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease. Brain Res. 1991, 558:312-314.
78. Croisier E., Moran L.B., Dexter D.T., Pearce R.K., Graeber M.B. Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J. Neuroinflamm. 2005, 3:214.
79. Cudkowicz M.E., Shefner J.M., Schoenfeld D.A., Zhang H., Andreasson K.I., Rothstein J.D., Drachman D.B. Trial of celecoxib in amyotrophic lateral sclerosis. Ann. Neurol. 2006, 60:22-31.
80. Cummings B.J., Su J.H., Geddes J.W., Van Nostrand W.E., Wagner S.L., Cunningham D.D., Cotman C.W. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease. Neuroscience 1992, 48:763-777.
81. Cunningham L.A., Short M.P., Breakefield X.O., Bohn M.C. Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease. Brain Res. 1994, 658:219-231.
82. Członkowska A., Kohutnicka M., Kurkowska-Jastrzebska I., Członkowski A. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 1996, 5:137-143.
83. D'Andrea M.R., Cole G.M., Ard M.D. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging 2004, 25:675-683.
84. Dass B., Olanow C.W., Kordower J.H. Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease. Neurology 2006, 66:S89-S103.
85. Davis J.B., McMurray H.F., Schubert D. The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 1992, 189:1096-1100.
86. Davoust N., Vuaillat C., Androdias G., Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol. 2008, 29:227-234.
87. Dawson T.M. Non-autonomous cell death in Parkinson's disease. Lancet Neurol. 2008, 7:474-475.
88. de Haas A.H., Boddeke H.W., Biber K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 2008, 56:888-894.
89. de Jong D., Jansen R., Hoefnagels W., Jellesma-Eggenkamp M., Verbeek M., Borm G., Kremer B. No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial. PLoS One 2008, 3:e1475.
90. De Yébenes J.G., Sánchez M., Mena M.A. Neurotrophic factors for the investigation and treatment of movement disorders. Neurotoxicol. Res. 2003, 5:119-138.
91. Delanty N., Vaughan C. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1998, 51:652.
92. Depino A.M., Earl C., Kaczmarczyk E., Ferrari C., Besedovsky H., del Rey A., Pitossi F.J., Oertel W.H. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur. J. Neurosci. 2003, 18:2731-2742.
93. DeWitt D.A., Perry G., Cohen M., Doller C., Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 1998, 149:329-340.
94. Dezawa M., Kanno H., Hoshino M., Cho H., Matsumoto N., Itokazu Y., Tajima N., Yamada H., Sawada H., Ishikawa H., Mimura T., Kitada M., Suzuki Y., Ide C. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 2004, 113:1701-1710.
95. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007, 10:608-614.
96. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol. Aging 2001, 22:1007-1012.
97. Dickstein D.L., Biron K.E., Ujiie M., Pfeifer C.G., Jeffries A.R., Jefferies W.A. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J. 2006, 20:426-433.
98. Dodel R.C., Hampel H., Du Y. Immunotherapy for Alzheimer's disease. Lancet Neurol. 2003, 2:215-220.
99. Dodge J.C., Haidet A.M., Yang W., Passini M.A., Hester M., Clarke J., Roskelley E.M., Treleaven C.M., Rizo L., Martin H., Kim S.H., Kaspar R., Taksir T.V., Griffiths D.A., Cheng S.H., Shihabuddin L.S., Kaspar B.K. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol. Ther. 2008, 16:1056-1064.
100. Du Y., Dodel R.C., Eastwood B.J., Bales K.R., Gao F., Lohmüller F., Müller U., Kurz A., Zimmer R., Evans R.M., Hake A., Gasser T., Oertel W.H., Griffin W.S., Paul S.M., Farlow M.R. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 2000, 55:480-483.
101. Egensperger R., Kösel S., von Eitzen U., Graeber M.B. Microglial activation in Alzheimer disease: Association with APOE genotype. Brain Pathol. 1998, 8:439-447.
102. Egensperger R., Maslim J., Bisti S., Hollander H., Stone J. Fate of DNA from retinal cells dying during development: uptake by microglia and macroglia (Muller cells). Dev. Brain Res. 1996, 97:1-8.
103. Eglitis M.A., Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4080-4085.
104. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
105. Eleuteri S., Polazzi E., Contestabile A. Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells. Neurosci. Lett. 2008, 448:74-78.
106. Elkabes S., DiCicco-Bloom E.-M., Black I.-B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 1996, 16:2508-2521.
107. Emerich D.F., Winn S.R., Hantraye P.M., Peschanski M., Chen E.Y., Chu Y., McDermott P., Baetge E.E., Kordower J.H. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 1997, 386:395-399.
108. Engelhardt J.I., Appel S.H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 1990, 47:1210-1216.
109. Eslamboli A., Georgievska B., Ridley R.M., Baker H.F., Muzyczka N., Burger C., Mandel R.J., Annett L., Kirik D. Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J. Neurosci. 2005, 25:769-777.
110. Etminan M., Carleton B.C., Samii A. Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study. J. Clin. Neurosci. 2008, 15:576-577.
111. Etminan M., Gill S., Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 2003, 327:128.
112. Farfara D., Lifshitz V., Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J. Cell. Mol. Med. 2008, 12:762-780.
113. Faust N., Huber M.C., Sippel A.E., Bonifer C. Different macrophage populations develop from embryonic/fetal and adult hematopoietic tissues. Exp. Hematol. 1997, 25:432-444.
114. Fedoroff S., Zhai R., Novak J.-P. Microglia and astroglia have a common progenitor cell. J. Neurosci. Res. 1997, 50:477-486.
115. Festoff B.W., Ameenuddin S., Arnold P.M., Wong A., Santacruz K.S., Citron B.A. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J. Neurochem. 2006, 97:1314-1326.
116. Fiala M., Cribbs D.H., Rosenthal M., Bernard G. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. J. Alzheimers Dis. 2007, 11:457-463.
117. Figueiredo C., Pais T.F., Gomes J.R., Chatterjee S. Neuron-microglia crosstalk up-regulates neuronal FGF-2 expression which mediates neuroprotection against excitotoxicity via JNK1/2. J. Neurochem. 2008, 107:73-85.
118. Flanary B. The role of microglial cellular senescence in the aging and Alzheimer diseased brain. Rejuvenation Res. 2005, 8:82-85.
119. Flanary B.E., Sammons N.W., Nguyen C., Walker D., Streit W.J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 2007, 10:61-74.
120. Flügel A., Bradl M., Kreutzberg G.-W., Graeber M.-B. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J. Neurosci. Res. 2001, 66:74-82.
121. Fourgeaud L., Boulanger L.-M. Synapse remodeling, compliments of the complement system. Cell 2007, 131:1034-1036.
122. Frackowiak J., Wisniewski H.M., Wegiel J., Merz G.S., Iqbal K., Wang K.C. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol. 1992, 84:225-233.
123. Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Mol. Neurodegener. 2009, 4:47.
124. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 1998, 152:307-317.
125. Frenkel D., Katz O., Solomon B. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11455-11459.
126. Frenkel D., Maron R., Burt D.S., Weiner H.L. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest. 2005, 115:2423-2433.
127. Frim D.M., Uhler T.A., Galpern W.R., Beal M.F., Breakefield X.O., Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:5104-5108.
128. Fuller S., Steele M., Münch G. Activated astroglia during chronic inflammation in Alzheimer's disease-Do they neglect their neurosupportive roles?. Mutat. Res. 2009, 11. (Epub. Sep. 11).
129. Gan L., Ye S., Chu A., Anton K., Yi S., Vincent V.A., von Schack D., Chin D., Murray J., Lohr S., Patthy L., Gonzalez-Zulueta M., Nikolich K., Urfer R. Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach. J. Biol. Chem. 2004, 279:5565-5572.
130. Gandy S., Walker L. Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates. Curr. Opin. Immunol. 2004, 16:607-615.
131. Gao H.M., Hong J.S., Zhang W., Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 2002, 22:782-790.
132. Gao H.M., Hong J.S., Zhang W., Liu B. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J. Neurosci. 2003, 23:1228-1236.
133. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 2002, 81:1285-1297.
134. García R., Aguiar J., Alberti E., de la Cuétara K., Pavón N. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem. Biophys. Res. Commun. 2004, 316:753-754.
135. Garden G.A., Möller T. Microglia biology in health and disease. J. Neuroimmune Pharmacol. 2006, 1:127-137.
136. Gebicke-Haerter P.J., Van Calker D., Nörenberg W., Illes P. Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases. Neurochem. Int. 1996, 29:1-12.
137. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 1995, 20:269-287.
138. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., Narni-Mancinelli E., Lauvau G. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 2008, 86:398-408.
139. Gelinas D.S., DaSilva K., Fenili D., St George-Hyslop P., McLaurin J. Immunotherapy for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(Suppl. 2):14657-14662.
140. Gerhard A., Banati R.B., Goerres G.B., Cagnin A., Myers R., Gunn R.N., Turkheimer F., Good C.D., Mathias C.J., Quinn N., Schwarz J., Brooks D.J. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003, 61(5):686-689.
141. Giorgini F., Möller T., Kwan W., Zwilling D., Wacker J.L., Hong S., Tsai L.C., Cheah C.S., Schwarcz R., Guidetti P., Muchowski P.J. Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J. Biol. Chem. 2008, 283(12):7390-7400.
142. Glanzer J.G., Enose Y., Wang T., Kadiu I., Gong N., Rozek W., Liu J., Schlautman J.D., Ciborowski P.S., Thomas M.P., Gendelman H.E. Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. J. Neurochem. 2007, 102:627-645.
143. Glezer I., Simard A.R., Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience 2007, 147:867-883.
144. Goñi F., Sigurdsson E.M. New directions towards safer and effective vaccines for Alzheimer's disease. Curr. Opin. Mol. Ther. 2005, 7:17-23.
145. Gordon, P.H., Moore, D.H., Miller, R.G., Florence, J.M., Verheijde, J.L., Doorish, C., Hilton, J.F., Spitalny, G.M., MacArthur, R.B., Mitsumoto, H., Neville, H.E., Boylan, K., Mozaffar, T., Belsh, J.M., Ravits, J., Bedlack, R.S., Graves, M.C., McCluskey, L.F., Barohn, R.J., Tandan, R., Western ALS Study Group, 2007. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol., 6, 1045-1053.
146. Gorlovoy P., Larionov S., Pham T.T., Neumann H. Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J. 2009, 23:2502-2513.
147. Gowing G., Philips T., Van Wijmeersch B., Audet J.N., Dewil M., Van Den Bosch L., Billiau A.D., Robberecht W., Julien J.P. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J. Neurosci. 2008, 28:10234-10244.
148. Graber J.J., Dhib-Jalbut S. Protective autoimmunity in the nervous system. Pharmacol. Ther. 2009, 121:147-159.
149. Grathwohl S.A., Kälin R.E., Bolmont T., Prokop S., Winkelmann G., Kaeser S.A., Odenthal J., Radde R., Eldh T., Gandy S., Aguzzi A., Staufenbiel M., Mathews P.M., Wolburg H., Heppner F.L., Jucker M. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat. Neurosci. 2009, 12:1361-1363.
150. Green R.C., Schneider L.S., Amato D.A., Beelen A.P., Wilcock G., Swabb E.A., Zavitz K.H. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 2009, 302:2557-2564. Tarenflurbil Phase 3 Study Group.
151. Griffin W.S., Liu L., Li Y., Mrak R.E., Barger S.W. Interleukin-1 mediates Alzheimer and Lewy body pathologies. J. Neuroinflamm. 2006, 16:3-5.
152. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 1998, 8:65-72.
153. Gruber H.E., Koenker R., Luchtman L.A., Willis R.C., Seegmiller J.E. Glial cells metabolically cooperate: a potential requirement for gene replacement therapy. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:6662-6666.
154. Guo Z., Iyun T., Fu W., Zhang P., Mattson M.P. Bone marrow transplantation reveals roles for brain macrophage/microglia TNF signaling and nitric oxide production in excitotoxic neuronal death. Neuromol. Med. 2004, 5:219-234.
155. Haass C., Hung A.Y., Selkoe D.J. Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J. Neurosci. 1991, 11:3783-3793.
156. Hahn C.N., del Pilar Martin M., Zhou X.Y., Mann L.W., d'Azzo A. Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14880-14885.
157. Hall E.D., Oostveen J.A., Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998, 23:249-256.
158. Hao C., Richardson A., Fedoroff S. Macrophage-like cells originate from neuroepithelium in culture: characterization and properties of the macrophage-like cells. Int. J. Dev. Neurosci. 1991, 9:1-14.
159. Hardy J., Selko D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
160. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 2001, 108:591-599.
161. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 2000, 355:286-287.
162. Hauss-Wegrzyniak B., Vraniak P., Wenk G.L. The effects of a novel NSAID on chronic neuroinflammation are age dependent. Neurobiol. Aging 1999, 20:305-313.
163. Hawkes C.A., McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1261-1266.
164. Henkel J.S., Beers D.R., Siklós L., Appel S.H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 2006, 31:427-437.
165. Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009, 4:389-398.
166. Henkel J.S., Engelhardt J.I., Siklós L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., Appel S.H. Presence of dendritic cells. MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 2004, 55:221-235.
167. Henry V., Paillé V., Lelan F., Brachet P., Damier P. Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamine. J. Neuropathol. Exp. Neurol. 2009, 68:1092-1102.
168. Herber D.L., Mercer M., Roth L.M., Symmonds K., Maloney J., Wilson N., Freeman M.J., Morgan D., Gordon M.N. Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J. Neuroimmune Pharmacol. 2007, 2:222-231.
169. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 2008, 28:8354-8360.
170. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009, 8:382-397.
171. Hirschberg D.L., Schwartz M. Macrophage recruitment to acutely injured central nervous system is inhibited by a resident factor: a basis for an immune-brain barrier. J. Neuroimmunol. 1995, 61:89-96.
172. Holmøy T. T cells in amyotrophic lateral sclerosis. Eur. J. Neurol. 2008, 15:360-366.
173. Hsiao H.Y., Chern Y. Targeting glial cells to elucidate the pathogenesis of Huntington's disease. Mol. Neurobiol. 2010, 41:248-255.
174. Huang F., Buttini M., Wyss-Coray T., McConlogue L., Kodama T., Pitas R.E., Mucke L. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors. Am. J. Pathol. 1999, 155:1741-1747.
175. Hurley S.D., O'Banion M.K., Song D.D., Arana F.S., Olschowka J.A., Haber S.N. Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys. Exp. Neurol. 2003, 184:659-668.
176. Hutchins K.D., Dickson D.W., Rashbaum W.-K., Lyman W.D. Localization of morphologically distinct microglial populations in the developing human fetal brain: implications for ontogeny. Brain Res. Dev. Brain Res. 1990, 55:95-102.
177. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell. Biol. 2009, 187:761-772.
178. Imai F., Suzuki H., Oda J., Ninomiya T., Ono K., Sano H., Sawada M. Neuroprotective effect of exogenous microglia in global brain ischemia. J. Cereb. Blood Flow Metab. 2007, 27:488-500.
179. Imbimbo B.P. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Expert Opin. Investig. Drugs 2009, 18:1147-1168.
180. in't Veld B.A., Launer L.J., Hoes A.W., Ott A., Hofman A., Breteler M.M., Stricker B.H., The Rotterdam Study NSAIDs and incident Alzheimer's disease. Neurobiol. Aging 1998, 19:607-611.
181. Isacson O., Dunnett S.B., Björklund A. Graft-induced behavioral recovery in an animal model of Huntington disease. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:2728-2732.
182. Isacson O., Kordower J.H. Future of cell and gene therapies for Parkinson's disease. Ann. Neurol. 2008, 64(Suppl. 2):S122-S138.
183. Ishizawa K., Komori T., Sasaki S., Arai N., Mizutani T., Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J. Neuropathol. Exp. Neurol. 2004, 63:43-52.
184. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 1989, 24:173-182.
185. Jantzen P.T., Connor K.E., DiCarlo G., Wenk G.L., Wallace J.L., Rojiani A.M., Coppola D., Morgan D., Gordon M.N. Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci. 2002, 22:2246-2254.
186. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., Westaway D. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000, 408:979-982.
187. Jiang Q., Lee C.Y., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., Mann K., Lamb B., Willson T.M., Collins J.L., Richardson J.C., Smith J.D., Comery T.A., Riddell D., Holtzman D.M., Tontonoz P., Landreth G.E. ApoE promotes the proteolytic degradation of Abeta. Neuron 2008, 58:681-693.
188. Jin H.K., Carter J.E., Huntley G.W., Schuchman E.H. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J. Clin. Invest. 2002, 109:1183-1191.
189. Jonakait G.M., Luskin M.B., Wei R., Tian X.F., Ni L. Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro. Dev. Biol. 1996, 177:85-95.
190. Jonakait G.-M., Wen Y., Wan Y., Ni L. Macrophage cell-conditioned medium promotes cholinergic differentiation of undifferentiated progenitors and synergizes with nerve growth factor action in the developing basal forebrain. Exp. Neurol. 2000, 161:285-296.
191. Kang J., Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J. Cell. Biol. 2007, 179:1219-1230.
192. Karplus T.M., Saag K.G. Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?. Drug Saf. 1998, 19:427-433.
193. Karussis D., Kassis I., Kurkalli B.G., Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J. Neurol. Sci. 2008, 265:131-135.
194. Kaspar B.K., Lladó J., Sherkat N., Rothstein J.D., Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003, 301:839-842.
195. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997, 48:1517-1521.
196. Kellner A., Matschke J., Bernreuther C., Moch H., Ferrer I., Glatzel M. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann. Neurol. 2009, 65:24-31.
197. Kiaei M., Kipiani K., Chen J., Calingasan N.Y., Beal M.F. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2005, 191:331-336.
198. Kiaei M., Kipiani K., Petri S., Chen J., Calingasan N.Y., Beal M.F. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2005, 2:246-254.
199. Kiaei M., Kipiani K., Petri S., Choi D.K., Chen J., Calingasan N.Y., Beal M.F. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2005, 93:403-411.
200. Kiaei M., Petri S., Kipiani K., Gardian G., Choi D.K., Chen J., Calingasan N.Y., Schafer P., Muller G.W., Stewart C., Hensley K., Beal M.F. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2006, 26:2467-2473.
201. Kida S., Steart P.-V., Zhang E.-T., Weller R.O. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol. 1993, 85:646-652.
202. Kiefer R., Streit W.J., Toyka K.V., Kreutzberg G.W., Hartung H.P. Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int. J. Dev. Neurosci. 1995, 13:331-339.
203. Kim B.J., Kim M.J., Park J.M., Lee S.H., Kim Y.J., Ryu S., Kim Y.H., Yoon B.W. Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J. Neurol. Sci. 2009, 279:70-75.
204. Kim Y.J., Park H.J., Lee G., Bang O.Y., Ahn Y.H., Joe E., Kim H.O., Lee P.H. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009, 57:13-23.
205. Kingham P.J., Pocock J.M. Microglial secreted cathepsin B induces neuronal apoptosis. J. Neurochem. 2001, 76:1475-1484.
206. Kipnis J., Schwartz M. Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol. Med. 2002, 8:319-323.
207. Klegeris A., Walker D.G., McGeer P.L. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem. Biophys. Res. Commun. 1994, 199:984-991.
208. Kokovay E., Cunningham L.A. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease. Neurobiol. Dis. 2005, 19:471-478.
209. Kopec K.K., Carroll R.T. Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J. Neurochem. 1998, 71:2123-2131.
210. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:10711-10716.
211. Korotzer A.R., Pike C.J., Cotman C.W. beta-Amyloid peptides induce degeneration of cultured rat microglia. Brain Res. 1993, 624:121-125.
212. Kriz J., Gowing G., Julien J.P. Efficient three-drug cocktail for disease induced by superoxide dismutase. Ann. Neurol. 2003, 53:429-436.
213. Kriz J., Nguyen M.D., Julien J.P. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2002, 10:268-278.
214. Kuwabara Y., Yokoyama A., Yang L., Toku K., Mori K., Takeda I., Shigekawa T., Zhang B., Maeda N., Sakanaka M., Tanaka J. Two populations of microglial cells isolated from rat primary mixed glial cultures. J. Neurosci. Res. 2003, 73:22-30.
215. Ladeby R., Wirenfeldt M., Garcia-Ovejero D., Fenger C., Dissing-Olesen L., Dalmau I., Finsen B. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 2005, 48:196-206.
216. Lai A.Y., Todd K.G. Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 2008, 56:259-270.
217. Lake B.D., Henderson D.C., Oakhill A., Vellodi A. Bone marrow transplantation in Batten disease (neuronal ceroid-lipofuscinosis), Will it work? Preliminary studies on coculture experiments and on bone marrow transplant in late infantile Batten disease. Am. J. Med. Genet. 1995, 57:369-373.
218. Lalancette-Hébert M., Gowing G., Simard A., Weng Y.C., Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 2007, 27:2596-2605.
219. Lambertsen K.L., Clausen B.H., Babcock A.A., Gregersen R., Fenger C., Nielsen H.H., Haugaard L.S., Wirenfeldt M., Nielsen M., Dagnaes-Hansen F., Bluethmann H., Faergeman N.J., Meldgaard M., Deierborg T., Finsen B. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 2009, 29:1319-1930.
220. Lassmann H., Hickey W.F. Radiation bone marrow chimeras as a tool to study microglia turnover in normal brain and inflammation. Clin. Neuropathol. 1993, 12:284-285.
221. Lawson L.J., Perry V., Dri P.-H., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.
222. Lazar D.A., Ellegala D.B., Avellino A.M., Dailey A.T., Andrus K., Kliot M. Modulation of macrophage and microglial responses to axonal injury in the peripheral and central nervous systems. Neurosurgery 1999, 45:593-600.
223. Lazarov-Spiegler O., Rapalino O., Agranov G., Schwartz M. Restricted inflammatory reaction in the CNS: a key impediment to axonal regeneration?. Mol. Med. Today 1998, 4:337-342.
224. Lazarov-Spiegler O., Solomon A.S., Zeev-Brann A.B., Hirschberg D.L., Lavie V., Schwartz M. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 1996, 10:1296-1302.
225. Le W., Rowe D., Xie W., Ortiz I., He Y., Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 2001, 21:8447-8455.
226. LeBlanc A.C., Papadopoulos M., Bélair C., Chu W., Crosato M., Powell J., Goodyer C.G. Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J. Neurochem. 1997, 68:1183-1190.
227. Lee J.K., Jin H.K., Endo S., Schuchman E.H., Carter J.E., Bae J.S. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-Beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010, 28:329-343.
228. Lee M., Schwab C., Yu S., McGeer E., McGeer P.L. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol. Aging 2009, 30:1523-1534.
229. Lee M., Sparatore A., Del Soldato P., McGeer E., McGeer P.L. Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia 2010, 58:103-113.
230. Lehrmann E., Kiefer R., Christensen T., Toyka K.V., Zimmer J., Diemer N.H., Hartung H.P., Finsen B. Microglia and macrophages are major sources of locally produced transforming growth factor-beta1 after transient middle cerebral artery occlusion in rats. Glia 1998, 24:437-448.
231. Leimig T., Mann L., del Martin M., Bonten P., Persons E., Knowles D., Allay J., Cunningham J.A., Nienhuis J., Smeyne A.W., d'Azzo R.A. Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood 2002, 99:3169-3178.
232. Lemere C.A., Maier M., Jiang L., Peng Y., Seabrook T.J. Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans. Rejuvenation Res. 2006, 9(Spring):77-84.
233. Leung, E., Guo, L., Bu, J., Maloof, M., Khoury, J.E., Geula, C., 2009. Microglia activation mediates fibrillar amyloid-beta toxicity in the aged primate cortex. Neurobiol. Aging (Epub ahead of print).
234. Li L.Y., Li J.T., Wu Q.Y., Li J., Feng Z.T., Liu S., Wang T.H. Transplantation of NGF-gene-modified bone marrow stromal cells into a rat model of Alzheimer' disease. J. Mol. Neurosci. 2008, 34:157-163.
235. Liang J., Takeuchi H., Jin S., Noda M., Li H., Doi Y., Kawanokuchi J., Sonobe Y., Mizuno T., Suzumura A. Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway. Brain Res. 2010, 1322:8-23.
236. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 1999, 5:1403-1409.
237. Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Ashe K.H., Frautschy S.A., Cole G.M. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 2000, 20:5709-5714.
238. Lim S.T., Airavaara M., Harvey B.K. Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol. Res. 2010, 61:14-26.
239. Lindberg C., Selenica M.L., Westlind-Danielsson A., Schultzberg M. Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. J. Mol. Neurosci. 2005, 27:1-12.
240. Lindvall O. Clinical application of neuronal grafts in Parkinson's disease. J. Neurol. 1994, 242:S54-S56.
241. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 2000, 293:607-617.
242. Liu J., Hong Z., Ding J., Liu J., Zhang J., Chen S. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. J. Proteome Res. 2008, 7:2033-2049.
243. Liu Y., Hao W., Dawson A., Liu S., Fassbender K. Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. J. Biol. Chem. 2009, 284:3691-3699.
244. Lo Bianco C., Déglon N., Pralong W., Aebischer P. Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease. Neurobiol. Dis. 2004, 17:283-289.
245. Lobsiger C.S., Cleveland D.W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 2007, 10:1355-1360.
246. Long-Smith C.M., Sullivan A.M., Nolan Y.M. The influence of microglia on the pathogenesis of Parkinson's disease. Prog. Neurobiol. 2009, 89:277-287.
247. Lönnqvist T., Vanhanen S.L., Vettenranta K., Autti T., Rapola J., Santavuori P., Saarinen-Pihkala U.M. Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis. Neurology 2001, 57:1411-1416.
248. Lu X., Bing G., Hagg T. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 2000, 97:285-291.
249. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
250. Lundberg C., Horellou P., Mallet J., Björklund A. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Exp. Neurol. 1996, 139:39-53.
251. Lunn J.S., Hefferan M.P., Marsala M., Feldman E.L. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors 2009, 27:133-140.
252. Lynch J.R., Morgan D., Mance J., Matthew W.D., Laskowitz D.T. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J. Neuroimmunol. 2001, 114:107-113.
253. Lynch M.A. The multifaceted profile of activated microglia. Mol. Neurobiol. 2009, 40:139-156.
254. Mackenzie I.R. Activated microglia in dementia with Lewy bodies. Neurology 2000, 55:132-134.
255. Mackenzie I.R. Anti-inflammatory drugs and Alzheimer-type pathology in aging. Neurology 2000, 54:732-734.
256. Mackenzie I.R., Munoz D.G. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 1998, 50:986-990.
257. Madinier A., Bertrand N., Mossiat C., Prigent-Tessier A., Beley A., Marie C., Garnier P. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009, 4:e8101.
258. Magnus T., Chan A., Grauer O., Toyka K.V., Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 2001, 167:5004-5010.
259. Maier M., Peng Y., Jiang L., Seabrook T.J., Carroll M.C., Lemere C.A. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J. Neurosci. 2008, 28:6333-6341.
260. Majed H.H., Chandran S., Niclou S.P., Nicholas R.S., Wilkins A., Wing M.G., Rhodes K.E., Spillantini M.G., Compston A. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J. Neurosci. 2006, 26:1730-1738.
261. Makar T.K., Bever C.T., Singh I.S., Royal W., Sahu S.N., Sura T.P., Sultana S., Sura K.T., Patel N., Dhib-Jalbut S., Trisler D. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 2009, 210:40-51.
262. Malm T.M., Magga J., Kuh G.F., Vatanen T., Koistinaho M., Koistinaho J. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease. Glia 2008, 56:1767-1779.
263. Mandrekar S., Jiang Q., Lee C.Y., Koenigsknecht-Talboo J., Holtzman D.M., Landreth G.E. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. 2009, 29:4252-4262.
264. Mangano E.N., Hayley S. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Neurobiol. Aging 2009, 30:1361-1378.
265. Marinova-Mutafchieva L., Sadeghian M., Broom L., Davis J.B., Medhurst A.D., Dexter D.T. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. J. Neurochem. 2009, 110:966-975.
266. Marin-Teva J.-L., Dusart I., Colin C., Gervais A., van Rooijen N., Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 2004, 41:535-547.
267. Martínez-Serrano A., Björklund A. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:1858-1863.
268. Martínez-Serrano A., Björklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J. Neurosci. 1996, 16:4604-4616.
269. Marx F., Blasko I., Pavelka M., Grubeck-Loebenstein B. The possible role of the immune system in Alzheimer's disease. Exp. Gerontol. 1998, 33:871-881.
270. Masliah E., Rockenstein E., Adame A., Alford M., Crews L., Hashimoto M., Seubert P., Lee M., Goldstein J., Chilcote T., Games D., Schenk D. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron 2005, 46:857-868.
271. Matsuura K., Makino H., Ogawa N. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 1997, 146:526-535.
272. McBride J.L., Kordower J.H. Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF. Prog. Brain Res. 2002, 138:421-432.
273. McBride J.L., Ramaswamy S., Gasmi M., Bartus R.T., Herzog C.D., Brandon E.P., Zhou L., Pitzer M.R., Berry-Kravis E.M., Kordower J.H. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9345-9350.
274. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001, 357:436-439.
275. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 1997, 17:2284-2294.
276. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 1989, 16:516-527.
277. McGeer P.L., Itagaki S., Akiyama H., McGeer E.G. Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 1988, 24:574-576.
278. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
279. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 1987, 9:195-200.
280. McGeer P.L., McGeer E., Rogers J., Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet 1990, 335:1037.
281. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21:195-218.
282. McGeer P.L., McGeer E.G. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch. Neurol. 2001, 58:1790-1792.
283. McGeer P.L., Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992, 42:447-449.
284. McGeer P.L., Schwab C., Parent A., Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann. Neurol. 2003, 54:599-604.
285. McKay S.M., Brooks D.-J., Hu P., McLachlan E.-M. Distinct types of microglial activation in white and grey matter of rat lumbosacral cord after mid-thoracic spinal transection. J. Neuropathol. Exp. Neurol. 2007, 66:698-710.
286. Meda L., Baron P., Prat E., Scarpini E., Scarlato G., Cassatella M.A., Rossi F. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J. Neuroimmunol. 1999, 93:45-52.
287. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374:647-650.
288. Meyer T., Maier A., Borisow N., Dullinger J.S., Splettstösser G., Ohlraun S., Münch C., Linke P. Thalidomide causes sinus bradycardia in ALS. J Neurol. 2008, 255:587-591.
289. Mezey E., Chandross K.J., Harta G., Maki R.A., McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000, 290:1779-1782.
290. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., Crain B. Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1364-1369.
291. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 2009, 210:3-12.
292. Minghetti L., Ajmone-Cat M.A., De Berardinis M.A., De Simone R. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res. Brain Res. Rev. 2005, 48:251-256.
293. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 1998, 54:99-125.
294. Mirza B., Hadberg H., Thomsen P., Moos T. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 2000, 95:425-432.
295. Mitrasinovic O.M., Grattan A., Robinson C.C., Lapustea N.B., Poon C., Ryan H., Phong C., Murphy G.M. Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system. J. Neurosci. 2005, 25:4442-4451.
296. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 1999, 5:49-55.
297. Möller J.C., Klein M.A., Haas S., Jones L.L., Kreutzberg G.W., Raivich G. Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia 1996, 17:121-132.
298. Monsonego A., Imitola J., Petrovic S., Zota V., Nemirovsky A., Baron R., Fisher Y., Owens T., Weiner H.L. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5048-5053.
299. Monsonego A., Maron R., Zota V., Selkoe D.J., Weiner H.L. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10273-10278.
300. Monsonego A., Zota V., Karni A., Krieger J.I., Bar-Or A., Bitan G., Budson A.E., Sperling R., Selkoe D.J., Weiner H.L. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 2003, 112:415-422.
301. Morgan D., Gordon M.N., Tan J., Wilcock D., Rojiani A.M. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J. Neuropathol. Exp. Neurol. 2005, 64:743-753.
302. Morgan D. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice. Neurochem. Int. 2006, 49:190-194.
303. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000, 408:982-985.
304. Mosley, R.L., Gendelman, H.E., 2010. Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders. Exp. Neurol. (Epub ahead of print).
305. Mount M.-P., Lira A., Grimes D., Smith P.-D., Faucher S., Slack R., Anisman H., Hayley S., Park D.-S. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J. Neurosci. 2007, 27:3328-3337.
306. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
307. Mrak R.E., Sheng J.G., Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 1995, 26:816-823.
308. Münch G., Robinson S.R. Potential neurotoxic inflammatory responses to Abeta vaccination in humans. J. Neural Transm. 2002, 109:1081-1087.
309. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007, 10:615-622.
310. Nagata K., Takei N., Nakajima K., Saito H., Kohsaka S. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J. Neurosci. Res. 1993, 34:357-363.
311. Nagatsu T., Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 2005, 11:999-1016.
312. Naito M., Umeda S., Yamamoto T., Moriyama H., Umezu H., Hasegawa G., Usuda H., Shultz L.-D., Takahashi K. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J. Leukoc. Biol. 1996, 59:133-138.
313. Najbauer J., Schuman E.M., Mamelak A.N. The aspirin metabolite sodium salicylate causes focal cerebral hemorrhage and cell death in rats with kainic acid-induced seizures. Neuroscience 2000, 99:107-117.
314. Nakajima K., Nagata K., Kohsaka S. Plasminogen mediates an interaction between microglia and dopaminergic neurons. Eur. Neurol. 1994, 34(Suppl. 3):10-16.
315. Napoli I., Neumann H. Microglial clearance function in health and disease. Neuroscience 2009, 158:1030-1038.
316. Netland E.E., Newton J.L., Majocha R.E., Tate B.A. Indomethacin reverses the microglial response to amyloid beta-protein. Neurobiol. Aging 1998, 19:201-204.
317. Neumann H. Control of glial immune function by neurons. Glia 2001, 36:191-199.
318. Neumann H., Kotter M.-R., Franklin R.-J. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295.
319. Neumann J., Gunzer M., Gutzeit H.O., Ullrich O., Reymann K.G., Dinkel K. Microglia provide neuroprotection after ischemia. FASEB J. 2006, 20:714-716.
320. Neumann J., Sauerzweig S., Ronicke R., Gunzer F., Dinkel K., Ullrich O., Gunzer M., Reymann K.G. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J. Neurosci. 2008, 28:5965-5975.
321. Neymotin A., Petri S., Calingasan N.Y., Wille E., Schafer P., Stewart C., Hensley K., Beal M.F., Kiaei M. Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2009, 220:191-197.
322. Norflus F., Tifft C.J., McDonald M.P., Goldstein G., Crawley J.N., Hoffmann A., Sandhoff K., Suzuki K., Proia R.L. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J. Clin. Invest. 1998, 101:1881-1888.
323. Ohgami T., Kitamoto T., Shin R.W., Kaneko Y., Ogomori K., Tateishi J. Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathol. 1991, 81:242-247.
324. Ohnishi S., Ito H., Suzuki Y., Adachi Y., Wate R., Zhang J., Nakano S., Kusaka H., Ikehara S. Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis. Brain Res. 2009, 1296:216-224.
325. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., Prockop D.J. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14638-14643.
326. Oken R.J. Towards a unifying hypothesis of neurodegenerative diseases and a concomitant rational strategy for their prophylaxis and therapy. Med. Hypotheses 1995, 45:341-342.
327. Okura Y., Kohyama K., Park I.K., Matsumoto Y. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model. J Neuropathol. Exp. Neurol. 2008, 67:1063-1071.
328. Olson L., Bäckman L., Ebendal T., Eriksdotter-Jönhagen M., Hoffer B., Humpel C., Freedman R., Giacobini M., Meyerson B., Nordberg A., et al. Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases. J. Neurol. 1994, 242(1 Suppl. 1):S12-S15.
329. Orr C.F., Rowe D.B., Halliday G.M. An inflammatory review of Parkinson's disease. Prog. Neurobiol. 2002, 68:325-340.
330. Orr C.F., Rowe D.B., Mizuno Y., Mori H., Halliday G.M. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 2005, 128:2665-2674.
331. Paresce D.M., Chung H., Maxfield F.R. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 1997, 272:29390-29397.
332. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 1996, 17:553-565.
333. Park L.C., Zhang H., Gibson G.E. Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech. Ageing Dev. 2001, 123(1):21-27. Dec.
334. Parkman R. The application of bone marrow transplantation to the treatment of genetic diseases. Science 1986, 232:1373-1378.
335. Pavese N., Gerhard A., Tai Y.F., Ho A.K., Turkheimer F., Barker R.A., Brooks D.J., Piccini P. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 2006, 66:1638-1643.
336. Pennisi E. Building a better aspirin. Science 1998, 280:1191-1192.
337. Perry V.-H., Crocker P.-R., Gordon S. The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J. Cell. Sci. 1992, 101:201-207.
338. Piao Y.S., Mori F., Hayashi S., Tanji K., Yoshimoto M., Kakita A., Wakabayashi K., Takahashi H. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. Acta Neuropathol. 2003, 105:403-409.
339. Pisati F., Bossolasco P., Meregalli M., Cova L., Belicchi M., Gavina M., Marchesi C., Calzarossa C., Soligo D., Lambertenghi-Deliliers G., Bresolin N., Silani V., Torrente Y., Polli E. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant. 2007, 16:41-55.
340. Pocock J.M., Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007, 30:527-535.
341. Polazzi E., Altamira L.E., Eleuteri S., Barbaro R., Casadio C., Contestabile A., Monti B. Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. J. Neurochem. 2009, 110:545-556.
342. Polazzi E., Contestabile A. Overactivation of LPS-stimulated microglial cells by co-cultured neurons or neuron-conditioned medium. J. Neuroimmunol. 2006, 172:104-111.
343. Polazzi E., Contestabile A. Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev. Neurosci. 2002, 13:221-242.
344. Polazzi E., Gianni T., Contestabile A. Microglial cells protect cerebellar granule neurons from apoptosis: evidence for reciprocal signaling. Glia 2001, 36:271-280.
345. Politis M., Pavese N., Tai Y.F., Tabrizi S.J., Barker R.A., Piccini P. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain 2008, 131:2860-2869.
346. Poon W.S., Lu G., Tsang K.S., Zhu X.L., Chen G.G., Ng H.K. Migration of bone marrow stem cells in ischaemic brain. Acta Neurochir. Suppl. 2006, 99:123-124.
347. Popat R.A., Tanner C.M., van den Eeden S.K., Bernstein A.L., Bloch D.A., Leimpeter A., McGuire V., Nelson L.M. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2007, 8:157-163.
348. Popovic N., Maingay M., Kirik D., Brundin P. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes. Exp. Neurol. 2005, 193:65-74.
349. Prewitt C.M., Niesman I.R., Kane C.J., Houlé J.D. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp. Neurol. 1997, 148:433-443.
350. Priller J., Flügel A., Wehner T., Boentert M., Haas C.-A, Prinz M., Fernandez-Klett F., Prass K., Bechmann I., De Boer B.-A., Frotscher M., Kreutzberg ., Persons G.-W., Dirnagl D.-A.U. Targeting gen-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 2001, 7:1356-1361.
351. Probst-Cousin S., Rickert C.H., Schmid K.W., Gullotta F. Cell death mechanisms in multiple system atrophy. J. Neuropathol. Exp. Neurol. 1998, 57:814-821.
352. Qin S., Colin C., Hinners I., Gervais A., Cheret C., Mallat M. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J. Neurosci. 2006, 26:3345-3356.
353. Rabchevsky A.G., Streit W.J. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J. Neurosci. Res. 1997, 47:34-48.
354. Ralay Ranaivo H., Craft J.M., Hu W., Guo L., Wing L.K., Van Eldik L.J., Watterson D.M. Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 2006, 26:662-670.
355. Ramaswamy S., Soderstrom K.E., Kordower J.H. Trophic factors therapy in Parkinson's disease. Prog. Brain Res. 2009, 175:201-216.
356. Ransohoff R.-M., Perry V.-H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
357. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 1998, 4:814-821.
358. Ren L., Lubrich B., Biber K., Gebicke-Haerter P.-J. Differential expression of inflammatory mediators in rat microglia cultured from different brain regions. Brain Res. Mol. Brain Res. 1999, 65:198-205.
359. Reynolds A.D., Glanzer J.G., Kadiu I., Ricardo-Dukelow M., Chaudhuri A., Ciborowski P., Cerny R., Gelman B., Thomas M.P., Mosley R.L., Gendelman H.E. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J. Neurochem. 2008, 104:1504-1525.
360. Reynolds A.D., Kadiu I., Garg S.K., Glanzer J.G., Nordgren T., Ciborowski P., Banerjee R., Gendelman H.E. Nitrated alpha-synuclein and microglial neuroregulatory activities. J. Neuroimmune Pharmacol. 2008, 3:59-74.
361. Reynolds A.D., Stone D.K., Mosley R.L., Gendelman H.E. Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. J. Proteome Res. 2009, 8:3497-3511.
362. Richardson A., Hao C., Fedoroff S. Microglia progenitor cells: a subpopulation in cultures of mouse neopallial astroglia. Glia 1993, 7:25-33.
363. Ridet J.L., Corti O., Pencalet P., Hanoun N., Hamon M., Philippon J., Mallet J. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes. Hum. Gene Ther. 1999, 10:271-280.
364. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 1988, 9:339-349.
365. Rogers J., Strohmeyer R., Kovelowski C.J., Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2002, 40:260-269.
366. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
367. Rosenmann H., Grigoriadis N., Karussis D., Boimel M., Touloumi O., Ovadia H., Abramsky O. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch. Neurol. 2006, 63:1459-1467.
368. Rozemuller A.J., Eikelenboom P., Theeuwes J.W., Jansen Steur E.N., de Vos R.A. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies. Acta Neuropathol. 2000, 100:701-708.
369. Sadan O., Bahat-Stromza M., Barhum Y., Levy Y.S., Pisnevsky A., Peretz H., Ilan A.B., Bulvik S., Shemesh N., Krepel D., Cohen Y., Melamed E., Offen D. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev. 2009, 18:1179-1190.
370. Sadan O., Shemesh N., Barzilay R., Bahat-Stromza M., Melamed E., Cohen Y., Offen D. Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells 2008, 26:2542-2551.
371. Saijo K., Winner B., Carson C.T., Collier J.G., Boyer L., Rosenfeld M.G., Gage F.H., Glass C.K. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009, 137:47-59.
372. Samii A., Etminan M., Wiens M.O., Jafari S. NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies. Drugs Aging 2009, 26:769-779.
373. Sanchez-Guajardo V., Febbraro F., Kirik D., Romero-Ramos M. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease. PLoS One 2010, 5:e8784.
374. Sapp E., Kegel K.B., Aronin N., Hashikawa T., Uchiyama Y., Tohyama K., Bhide P.G., Vonsattel J.P., DiFiglia M. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 2001, 60:161-172.
375. Savchenko V.-L., McKanna J.-A., Nikonenko I.-R., Skibo G.-G. Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience 2000, 96:195-203.
376. Schaeffer E.L., Novaes B.A., da Silva E.R., Skaf H.D., Mendes-Neto A.G. Strategies to promote differentiation of newborn neurons into mature functional cells in Alzheimer brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1087-1102.
377. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999, 400:173-177.
378. Schnell L., Fearn S., Klassen H., Schwab M.E., Perry V.H. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 1999, 11:3648-3658.
379. Schwab C., McGeer P.L. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J. Alzheimers Dis. 2008, 13:359-369.
380. Schwartz M. Modulating the immune system: a vaccine for glaucoma?. Can. J. Ophthalmol. 2007, 42:439-441.
381. Schwartz M., Bukshpan S., Kunis G. Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis: the need for disease-specific approaches. Bio Drugs 2008, 22:293-299.
382. Schwartz M., Butovsky O., Brück W., Hanisch U.K. Microglial phenotype: is the commitment reversible?. Trends Neurosci. 2006, 29:68-74.
383. Schwartz M., Kipnis J. A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. Trends Pharmacol. Sci. 2004, 25:407-412.
384. Schwartz M., Lazarov-Spiegler O., Rapalino O., Agranov I., Velan G., Hadani M. Potential repair of rat spinal cord injuries using stimulated homologous macrophages. Neurosurgery 1999, 44:1041-1045.
385. Schwartz M., London A., Shechter R. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Neuroscience 2009, 158:1133-1142.
386. Schwarz E.J., Alexander G.M., Prockop D.J., Azizi S.A. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther. 1999, 10:2539-2549.
387. Schwarz E.J., Reger R.L., Alexander G.M., Class R., Azizi S.A., Prockop D.J. Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. Gene Ther. 2001, 8:1214-1223.
388. Schwarz S.C., Seufferlein T., Liptay S., Schmid R.M., Kasischke K., Foster O.J., Daniel S., Schwarz J. Microglial activation in multiple system atrophy: a potential role for NF-kappaB/rel proteins. Neuroreport 1998, 9:3029-3032.
389. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C., Younkin S.G., Brunden K.R. Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol. Aging 1995, 16:737-745.
390. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6(7):e1000113.
391. Shen Y., Meri S. Yin and Yang: complement activation and regulation in Alzheimer's disease. Prog. Neurobiol. 2003, 70:463-472.
392. Sheng J.G., Mrak R.E., Griffin W.S. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 1997, 56:285-290.
393. Sherer T.B., Betarbet R., Kim J.H., Greenamyre J.T. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci. Lett. 2003, 341:87-90.
394. Shevtsova Z., Malik J.M., Michel U., Bähr M., Kügler S. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp. Physiol. 2005, 90:53-59.
395. Shoemaker J.L., Seely K.A., Reed R.L., Crow J.P., Prather P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem. 2007, 101:87-98.
396. Simard A.R., Rivest S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 2004, 18:998-1000.
397. Simard A.R., Rivest S. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol. Psychiatry 2006, 11:327-335.
398. Simard A.R., Rivest S. Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 2007, 504:716-729.
399. Simard A.R., Soulet D., Gowing G., Julien J.P., Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49:489-502.
400. Skaper S.D. The brain as a target for inflammatory processes and neuroprotective strategies. Ann. N. Y. Acad. Sci. 2007, 1122:23-34.
401. Smith G.M., Hale J., Pasnikowski E.M., Lindsay R.M., Wong V., Rudge J.S. Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal populations in vitro. Exp. Neurol. 1996, 139:156-166.
402. Solomon J.N., Lewis C.A., Ajami B., Corbel S.Y., Rossi F.M., Krieger C. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia 2006, 53:744-753.
403. Soulet D., Rivest S. Bone-marrow-derived microglia: myth or reality?. Curr. Opin. Pharmacol. 2008, 8:508-518.
404. Spranger M., Fontana A. Activation of microglia: a dangerous interlude in immune function in the brain. Neuroscientist 1996, 2:293-299.
405. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J. 2006, 20:670-682.
406. Stalder M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 1999, 154:1673-1684.
407. Stefanova N., Reindl M., Neumann M., Kahle P.J., Poewe W., Wenning G.K. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov. Disord. 2007, 22:2196-2203.
408. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
409. Stewart W.F., Kawas C., Corrada M., Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48:626-632.
410. Streit W.J. Microglia and macrophages in the developing CNS. Neurotoxicology 2001, 22:619-624.
411. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 2004, 7:1-8.
412. Streit W.J. Microglia and implications for Alzheimer's disease. Brain Res. Brain Res. Rev. 2005, 48:234-239.
413. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29:506-510.
414. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 1998, 152:74-87.
415. Streit W.J., Xue Q.S. Life and death of microglia. J. Neuroimmune Pharmacol. 2009, 4:371-379.
416. Syková E., Jendelová P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 2007, 14:1336-1342.
417. Tai Y.F., Pavese N., Gerhard A., Tabrizi S.J., Barker R.A., Brooks D.J., Piccini P. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007, 130:1759-1766.
418. Takahashi K. Development and differentiation of macrophages and related cells: historical review and current concepts. J. Clin. Exp. Hemat. 2001, 41:1-33.
419. Takahashi K., Naito M. Development, differentiation, and proliferation of macrophages in the rat yolk sac. Tissue Cell 1993, 25:351-362.
420. Taylor D.L., Diemel L.T., Pocock J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci. 2003, 23:2150-2160.
421. Teismann P., Tieu K., Cohen O., Choi D.K., Wu D.C., Marks D., Vila M., Jackson-Lewis V., Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov. Disord. 2003, 18:121-129.
422. Theele D.P., Streit W.J. A chronicle of microglial ontogeny. Glia 1993, 7:5-8.
423. Thored P., Heldmann U., Gomes-Leal W., Gisler R., Darsalia V., Taneera J., Nygren J.M., Jacobsen S.E., Ekdahl C.T., Kokaia Z., Lindvall O. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 2009, 57:835-849.
424. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 2001, 21:2580-2588.
425. Toku K., Tanaka J., Yano H., Desaki J., Zhang B., Yang L., Ishihara K., Sakanaka M., Maeda N. Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J. Neurosci. Res. 1998, 53:415-425.
426. Tondreau T., Dejeneffe M., Meuleman N., Stamatopoulos B., Delforge A., Martiat P., Bron D., Lagneaux L. Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC Genomics 2008, 9:166.
427. Tsai S.J. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects. Med. Hypotheses 2007, 69:1219-1221.
428. Tsuji D., Kuroki A., Ishibashi Y., Itakura T., Itoh K. Metabolic correction in microglia derived from Sandhoff disease model mice. J. Neurochem. 2005, 94:1631-1638.
429. Turrin N.P., Rivest S. Molecular and cellular immune mediators of neuroprotection. Mol. Neurobiol. 2006, 34:221-242.
430. Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 2002, 13:1067-1070.
431. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?. Immunol. Today 1991, 12:217-219.
432. Varvel N.H., Bhaskar K., Kounnas M.Z., Wagner S.L., Yang Y., Lamb B.T., Herrup K. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J. Clin. Invest. 2009, 119:3692-3702.
433. Vercelli A., Mereuta O.M., Garbossa D., Muraca G., Mareschi K., Rustichelli D., Ferrero I., Mazzini L., Madon E., Fagioli F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2008, 31:395-405.
434. Vila M., Jackson-Lewis V., Guégan C., Wu D.C., Teismann P., Choi D.K., Tieu K., Przedborski S. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 2001, 14:483-489.
435. Vitry S., Bertrand J.Y., Cumano A., Dubois-Dalcq M. Primordial hematopoietic stem cells generate microglia but not myelin-forming cells in a neural environment. J. Neurosci. 2003, 23:10724-10731.
436. Wahner A.D., Sinsheimer J.S., Bronstein J.M., Ritz B. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch. Neurol. 2007, 64:836-840.
437. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29:3974-3980.
438. Walkley S.U., Thrall M.A., Dobrenis K., Huang M., March P.A., Siegel D.A., Wurzelmann S. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:2970-2974.
439. Walton N.M., Sutter B.M., Laywell E.D., Levkoff L.H., Kearns S.M., Marshall G.P., Scheffler B., Steindler D.A. Microglia instruct subventricular zone neurogenesis. Glia 2006, 54:815-825.
440. Wang C.C., Wu C.H., Shieh J.Y., Wen C.Y., Ling E.A. Immunohistochemical study of amoeboid microglial cells in fetal rat brain. J. Anat. 1996, 189:567-574.
441. Wang L., Muramatsu S., Lu Y., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Hanazono Y., Kume A., Urano F., Ichinose H., Nagatsu T., Nakano I., Ozawa K. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther. 2002, 9:381-389.
442. Wang L., Sharma K., Grisotti G., Roos R.P. The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis. Neurobiol. Dis. 2009, 35:234-240.
443. Warner T.D., Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004, 18:790-804.
444. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., Kang D.E., Marquez-Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 2001, 414:212-216.
445. Wegiel J., Wang K.C., Imaki H., Rubenstein R., Wronska A., Osuchowski M., Lipinski W.J., Walker L.C., LeVine H. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol. Aging 2001, 22:49-61.
446. West M., Mhatre M., Ceballos A., Floyd R.A., Grammas P., Gabbita S.P., Hamdheydari L., Mai T., Mou S., Pye Q.N., Stewart C., West S., Williamson K.S., Zemlan F., Hensley K. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J. Neurochem. 2004, 91:133-143.
447. Weydt P., Yuen E.C., Ransom B.R., Möller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 2004, 48:179-182.
448. Whitney N.P., Eidem T.M., Peng H., Huang Y., Zheng J.C. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 2009, 108:1343-1359.
449. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 2007, 150:963-976.
450. Wilcock D.M., Gharkholonarehe N., Van Nostrand W.E., Davis J., Vitek M.P., Colton C.A. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease. J. Neurosci. 2009, 29:7957-7965.
451. Wilcock D.M., Munireddy S.K., Rosenthal A., Ugen K.E., Gordon M.N., Morgan D. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiol. Dis. 2004, 15:11-20.
452. Wilcock D.M., Rojiani A., Rosenthal A., Levkowitz G., Subbarao S., Alamed J., Wilson D., Wilson N., Freeman M.J., Gordon M.N., Morgan D. Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J. Neurosci. 2004, 24:6144-6151.
453. Wilms H., Rosenstiel P., Sievers J., Deuschl G., Lucius R. Cerebrospinal fluid from patients with neurodegenerative and neuroinflammatory diseases: no evidence for rat glial activation in vitro. Neurosci. Lett. 2001, 314:107-110.
454. Wirenfeldt M., Babcock A.-A., Ladeby R., Lambertsen K.-L., Dagnaes-Hansen F., Leslie R.-G., Owens T., Finsen B. Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J. Neurosci. Res. 2005, 82:507-514.
455. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 2002, 22:1763-1771.
456. Wu Q., Combs C., Cannady S.B., Geldmacher D.S., Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol. Aging 2000, 21:797-806.
457. Wu X.F., Block M.L., Zhang W., Qin L., Wilson B., Zhang W.Q., Veronesi B., Hong J.S. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxd. Redox Signal. 2005, 7:654-661.
458. Wyss-Coray T., Mucke L. Ibuprofen, inflammation and Alzheimer disease. Nat. Med. 2000, 6:973-974.
459. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.
460. Yan Q., Zhang J., Liu H., Babu-Khan S., Vassar R., Biere A.L., Citron M., Landreth G. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 2003, 23:7504-7509.
461. Yanagisawa D., Kitamura Y., Takata K., Hide I., Nakata Y., Taniguchi T. Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in rats. Biol. Pharm. Bull. 2008, 31:1121-1130.
462. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
463. Younkin S.G. Amyloid beta vaccination: reduced plaques and improved cognition. Nat. Med. 2001, 7:18-19.
464. Zandi P.P., Breitner J.C. Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence. Neurobiol. Aging 2001, 22:811-817.
465. Zeev-Brann A.B., Lazarov-Spiegler O., Brenner T., Schwartz M. Differential effects of central and peripheral nerves on macrophages and microglia. Glia 1998, 23:181-190.
466. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., Wilson B., Zhang W., Zhou Y., Hong J.S., Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 2005, 19:533-542.
467. Zhao W., Beers D.R., Henkel J.S., Zhang W., Urushitani M., Julien J.P., Appel S.H. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 2010, 58:231-243.
468. Zhou Y., Wang Y., Kovacs M., Jin J., Zhang J. Microglial activation induced by neurodegeneration: a proteomic analysis. Mol. Cell. Proteomics 2005, 4:1471-1479.
469. Zietlow R., Dunnett S.B., Fawcett J.W. The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur. J. Neurosci. 1999, 11:1657-1667.
470. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.